Clinical Trials Directory

Trials / Unknown

UnknownNCT01582607

Subarachnoid Administration of Levobupivacaine for Cesarean Section

Intrathecal Plain Bupivacaine, Ropivacaine and Levo-bupivacaine With or Without Fentanyl for Elective c Section.

Status
Unknown
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
130 (estimated)
Sponsor
University of Patras · Academic / Other
Sex
Female
Age
18 Years – 40 Years
Healthy volunteers
Accepted

Summary

The purpose of the investigators study is to compare the clinical effects and side-effects of these three local anaesthetics as sole agents or with the supplementation with fentanyl for c-section, especially when administered in doses achieving approximately an ED 50.

Detailed description

Intrathecal (i.t.) administration of isobaric bupivacaine, ropivacaine and levobupivacaine with or without addition of fentanyl for c-section do not exist to date . Parturients scheduled for elective caesarean section will be allocated to receive double-blindly i.t. isobaric bupivacaine 10 mg, ropivacaine 15mg , levobupivacaine 10mg or the same local anaesthetics with 10 μg fentanyl respectively. Sensory block (pin prick test) and motor block (Bromage scale) profile, intraoperative and postoperative analgesia, haemodynamics and side effects will be assessed.

Conditions

Interventions

TypeNameDescription
DRUGBupivacaine plain2.0 mL (10mg) plain bupivacaine hydrochloride 0.5% intrathecally
DRUGRopivacaine plain2.0 ml (15mg) plain ropivacaine 0.75% intrathecally
DRUGLevobupivacaine plain2.0 ml (10mg) plain levo-bupivacaine hydrochloride 0.5% intrathecally
DRUGbupivacaine plain +fentanyl2.0 ml (10mg) plain bupivacaine 0.5% with 0.2 ml (10 μg) fentanyl intrathecally
DRUGropivacaine plain +. fentanyl2.0 ml (15mg) plain ropivacaine 0.75% with 0.2 ml (10 μg) fentanyl intrathecally
DRUGLevobupivacaine plain +fentanyl2.0 ml (10mg) plain levo-bupivacaine 0.5% with 0.2 ml (10 μg) fentanyl intrathecally

Timeline

Start date
2010-01-01
Primary completion
2012-04-01
Completion
2012-05-01
First posted
2012-04-20
Last updated
2012-04-20

Locations

1 site across 1 country: Greece

Source: ClinicalTrials.gov record NCT01582607. Inclusion in this directory is not an endorsement.